The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVela Technologies Regulatory News (VELA)

Share Price Information for Vela Technologies (VELA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.012
Bid: 0.011
Ask: 0.013
Change: 0.00 (0.00%)
Spread: 0.002 (18.182%)
Open: 0.012
High: 0.012
Low: 0.012
Prev. Close: 0.012
VELA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Investment Update

10 Feb 2023 07:00

RNS Number : 5148P
Vela Technologies PLC
10 February 2023
 

10 February 2023

Vela Technologies plc

("Vela" or "the Company")

Quarterly Investment Update

The Board of Vela (AIM:VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to report an update for the quarter ended 31 December 2022.

Executive Director, James Normand, commented:

"I am pleased to report that Vela's gross asset value increased by 8.3% during the quarter ended 31 December 2022. This was largely attributable to a rise in the quoted price for EnSilica's shares in this period, which we believe reflects the market's recent greater appreciation of the commercial prospects of the business which prompted us to invest in the company at the pre-IPO stage a year ago. We have taken the opportunity to crystallise some of this appreciation by selling about one third of our investment in EnSilica, As a result Vela's cash resources have been replenished, thus putting the Company in a position where it can take advantage of promising investment opportunities that continue to be shown to us."

Key numbers as at 31 December 2022*:

· The value of Vela's total assets increased during the quarter by £532,000 (8.3%) to £6,933,000.

· Vela's portfolio comprised a total of 13 active investments (30 September 2022 - 13). Two of these investments were unquoted, ten were quoted, and the final investment was the interest in future royalties from the Covid-19 remedy being developed by St George's Street Capital Limited (which is held in the balance sheet as a financial asset).

· The fair value of the investment portfolio was £6,068,000 (30 September 2022 - £5,896,000).

· The change in the value of the investment portfolio reflects disposals of investments valued at £254,000 at 30 September 2022 (generating a realised profit of £133,000), a further investment of £100,000 in Northcoders Group plc ('Northcoders') and a net unrealised increase in the fair value of the investment portfolio of £327,000.

· Vela's cash balances increased to £864,000 as at 31 December 2022 (30 September 2022 - £646,000).

\* The figures contained within this quarterly investment update at 31 December 2022 and at 30 September 2022 are taken from unaudited management information.

Investments traded on a recognised stock market are valued using the accounting policies outlined in the notes to the annual financial statements. Unlisted investments and other financial assets are stated at the values attributed to them in the audited balance sheet as at 31 March 2022, unless there has been a transaction since that date which suggests a materially different valuation.

Key developments in the quarter:

· The Company held its annual general meeting on 25 October 2022 and all resolutions were duly passed.

· In order to maintain Vela's percentage interest in this thriving business, a further investment of £100,000 was made in Northcoders in November 2022 as part of a secondary placing by that company.

· During the quarter Vela sold an aggregate of 565,000 shares in EnSilica plc ('EnSilica'), generating gross proceeds of £387,000 and a realised profit of £133,000.

· Antony Laiker resigned from the board on 20 October 2022.

Key developments in investee companies in the quarter:

· On 17 October EnSilica announced strong results for the year ended 31 May 2022, reporting an increase of 77% in turnover. In addition, EnSilica announced two new contracts with existing customers on 12 December worth $3.6 million.

· On 29 November MTI Wireless Edge Ltd reported a significant contract win worth $0.75 million.

· On 21 November Northcoders announced that it had successfully completed a placing (in which Vela made a further investment).

· On 14 December Northcoders announced a significant contract win with R2 Factory, part of Rolls Royce, worth £0.45 million.

· Cornerstone FS PLC implemented a change of senior management (announced on 11 October) and revised its business plan. On 11 January 2023 a trading update for the year ended 31 December 2022 was announced and indicated a turnround in its fortunes, with unaudited turnover ahead of market expectations.

· On 26 January 2023 Skillcast Group plc published a positive trading update for the year ended 31 December 2022 and expressed confidence that it continues to expect to achieve the objectives set out at the time of its admission to AIM in December 2021.

Developments since 31 December 2022:

· On 20 January 2023 Vela invested £49,000 in Ethernity Networks Limited.

· On 26 January 2023 Mode Global Holdings plc announced the cessation of activities, following the collapse of the crypto-currency markets. The residual management is endeavouring to salvage some value for shareholders.

Investment portfolio

At 31 December 2022 the Company's portfolio of investments was valued at £6,068,000 and comprised equity or loan interests in the following 13 companies:

· Community Social Investment Limited (formerly WeShop Limited)

· Cornerstone FS PLC

· Aeristech Limited

· EnSilica plc

· Igraine PLC

· Kanabo Group Plc

· MTI Wireless Edge Ltd.

· Mode Global Holdings plc

· Rural Broadband Solutions PLC

· Northcoders Group plc

· Skillcast Group plc

· St George Street Capital Limited

· TruSpine Technologies plc

Since the publication of the last quarterly update on 8 November 2022, the Board of Vela has met with representatives of the following investee companies:

· Aeristech Limited

· Cornerstone FS PLC

· EnSilica plc

· Igraine PLC

· MTI Wireless Edge Ltd

· Skillcast Group plc

· St George Street Capital Limited

Vela has continued to explore opportunities to realise the value in its 8% economic interest in the Covid-19/diabetes drug AZD1656, which remains in the course of development and commercialisation by St George Street Capital Limited.

 

For further information, please contact:

Vela Technologies plc

Brent Fitzpatrick, Non-Executive Chairman

James Normand, Executive Director

 

Tel: +44 (0) 7421 728875

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0) 20 3328 5656

Nick Athanas / Piers Shimwell

 

Peterhouse Capital Limited (Broker)

Tel: +44 (0) 20 7469 0930

Lucy Williams / Duncan Vasey / Eran Zucker

 

Novus Communications (PR and IR Adviser)

Tel: +44 (0) 20 7448 9839

Alan Green / Jacqueline Briscoe

 

 

About Vela Technologies

Vela Technologies plc (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments. Vela's investee companies have either developed ways of utilising technology or are developing technology with a view to disrupting the businesses or sector in which they operate. Vela Technologies will also invest in already-listed companies where valuations offer additional opportunities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDLKLLBXLLFBBF
Date   Source Headline
26th Mar 20247:00 amRNSIssue of Equity
26th Feb 20241:21 pmRNSHolding in Company
23rd Feb 202412:15 pmRNSQuarterly Investment Update
8th Jan 202411:49 amRNSHolding(s) in Company
22nd Dec 20237:00 amRNSInterim Results
13th Dec 20237:00 amRNSQuarterly Investment Update
11th Dec 20232:19 pmRNSResult of AGM
5th Dec 202311:04 amRNSHolding in Company
1st Dec 20233:02 pmRNSExercise of Put Option
17th Nov 20238:58 amRNSNotice of AGM
28th Sep 20237:00 amRNSFinal results for the year ended 31 March 2023
27th Sep 20237:00 amRNSQuarterly Investment Update
21st Sep 20239:01 amRNSUpdate re. Economic Interest in AZD1656
8th Sep 20233:18 pmRNSFurther update re. Economic Interest in AZD1656
7th Sep 20237:00 amRNSUpdate re. Economic Interest in AZD1656
5th Sep 20238:50 amRNSUpdate on investment in Tribe Technology Group
15th Aug 20237:00 amRNSUpdate re. Economic Interest in AZD1656
12th Jun 202311:11 amRNSHolding in Company
6th Jun 20237:00 amRNSQuarterly Investment Update
23rd May 202311:45 amRNSInvestment in Tribe Technology Group Limited
15th May 20231:23 pmRNSUpdate re. Economic Interest in AZD1656
20th Apr 20233:01 pmRNSOption for potential sale of interest in AZD1656
14th Mar 20232:57 pmRNSInvestment in EnSilica plc
10th Feb 20237:00 amRNSQuarterly Investment Update
20th Jan 202312:27 pmRNSInvestment in Ethernity Networks Ltd
15th Dec 20227:00 amRNSInterim Results
6th Dec 20227:00 amRNSUpdate re. investment in EnSilica
28th Nov 20227:00 amRNSFurther investment in Northcoders Group plc
9th Nov 20229:00 amRNSUpdate re. AZD1656
8th Nov 20227:00 amRNSQuarterly Investment Update
25th Oct 202212:49 pmRNSResult of AGM
20th Oct 20221:52 pmRNSHolding(s) in Company
20th Oct 20227:52 amRNSBoard Change
28th Sep 20227:00 amRNSFinal results for the year ended 31 March 2022
2nd Sep 20227:40 amRNSStrategic Update
18th Aug 20229:53 amRNSUpdate re. St George Street Capital COVID-19 trial
22nd Jul 20227:00 amRNSQuarterly Investment Update
21st Jul 20221:40 pmRNSAppointment of Non-Executive Director
11th Jul 20227:00 amRNSHolding in Company
6th Jul 202212:07 pmRNSUpdate on investment - Community Social Investment
1st Jul 20221:27 pmRNSHolding(s) in Company
23rd Jun 202212:28 pmRNSInvestment in TruSpine Technologies plc
14th Jun 202212:49 pmRNSFurther update re TruSpine Technologies plc
14th Jun 20227:00 amRNSStatement re. potential investment in TruSpine
19th May 20221:26 pmRNSUpdate re. investment in EnSilica
3rd May 20227:00 amRNSQuarterly Investment Update and Change of Broker
26th Apr 20227:00 amRNSAppointment of PR and IR Adviser
30th Mar 20221:15 pmRNSAcquisition of a 28.8% interest in Igraine plc
7th Mar 20227:15 amRNSUpdate re. St George Street Capital COVID-19 trial
8th Feb 20221:30 pmRNSTR-1:Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.